Russia signed agreement with Chinese laboratory to produce 100 million doses of Sputnik V vaccine

Russian sovereign wealth fund RDIF announced on Monday that it had agreed with the firm Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.

The effectiveness of the Russian vaccine is 91.6% and the collaboration with Hualan, one of the main vaccine manufacturers of the Asian giant, will allow Russia to “significantly increase the production capacities” of Sputnik V, which will also be manufactured in Serbia and India, among other countries.

“China is one of the main partners in the production of the Russian vaccine, which is already used in virtually all parts of the world to protect people’s health, ”he said. Kirill Dmitriev, Executive Director of RDIF. Russian leaders said the two sides are committed to establishing a long-term partnership for vaccine production.

According to Russia’s sovereign wealth fund, this number of doses will be enough to vaccinate more than 50 million people. So far, Sputnik V has been registered in 60 countries with a total population of 3,000 million people.

But Moscow, rather than signing sales agreements, focused on expanding production capacities, moving them abroad.

At the end of March, he agreed with the company farmacéutica china Shenzhen Yuanxing Gene-tech make 60 million doses.

Previously, he had signed with other major producers in India. It is Virchow Biotech (300 million dose), Stelis (200 million) O Hetero (100 million). In Virchow’s case, RDIF said the technology transfer would be completed in the second quarter of 2021 and would be followed by full-scale commercial production.

“Partnerships for vaccines are the only way to overcome the pandemic. The world continues its fight against the coronavirus, and we are seeing increasing interest in Sputnik V “Dmitriev said then.

The vaccine is based on a well-researched and proven human adenoviral vector platform and uses two different vectors for the two injections, providing longer lasting immunity than vaccines which use the same delivery mechanism for both. injections.

(With information from EFE)

KEEP READING: